Results
47
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
47 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
IVVD | US$1.15 | -4.2% | -32.4% | US$137.4m | US$8.65 | PS60.7x | E70.4% | n/a | ||
ARDX | US$6.65 | 8.5% | 63.0% | US$1.6b | US$11.28 | PS7.5x | E66.3% | n/a | ||
BPMC | US$92.55 | 0.9% | 84.3% | US$5.9b | US$127.35 | PS16.2x | E67.4% | n/a | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
SLNO | US$49.13 | -4.8% | 66.5% | US$1.9b | US$70.29 | PB6.8x | E68.2% | n/a | ||
MGTX | US$4.26 | 1.9% | -13.2% | US$329.7m | US$20.60 | PS40.6x | E7.8% | n/a | ||
MDGL | US$212.43 | -9.0% | 45.5% | US$4.6b | US$360.57 | PS315.1x | E68.1% | n/a | ||
CLRB | US$2.04 | -1.4% | -22.7% | US$73.1m | US$16.33 | PB8x | E67.7% | n/a | ||
SWTX | US$32.28 | -6.1% | 39.6% | US$2.4b | US$68.13 | PS27.8x | E75.6% | n/a | ||
CAPR | US$9.95 | 97.0% | 190.9% | US$351.6m | US$31.00 | PS12.9x | E68.7% | n/a | ||
TSVT | US$4.93 | -2.4% | 25.8% | US$253.9m | US$8.25 | PS5.8x | E76.5% | n/a | ||
ENSC | US$0.29 | -10.6% | -79.1% | US$3.2m | US$8.60 | PS2.2x | E99.1% | n/a | ||
URGN | US$12.90 | -4.7% | -7.9% | US$543.3m | US$43.10 | PS6.4x | E55.1% | n/a | ||
ALDX | US$5.50 | -6.6% | -17.7% | US$326.8m | US$10.00 | PB3.3x | E62.3% | n/a | ||
ATYR | US$1.77 | -2.7% | 12.0% | US$134.2m | US$22.00 | PS228.2x | E67.4% | n/a | ||
PGEN | US$0.95 | -4.9% | -33.3% | US$272.6m | US$6.00 | PS62.1x | E64.1% | n/a | ||
ARQT | US$9.36 | -7.8% | 76.3% | US$1.1b | US$18.57 | PS8.3x | E69.3% | n/a | ||
CYCC | US$1.03 | 5.1% | -80.6% | US$2.0m | US$11.00 | PS25.4x | E71.5% | n/a | ||
XOMA | US$26.00 | -7.8% | 84.5% | US$304.3m | US$83.00 | PS20x | E74.3% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
PTN | US$0.84 | -34.3% | -44.3% | US$16.3m | US$11.50 | PS2.8x | E84.6% | n/a | ||
RYTM | US$51.35 | -2.7% | 124.0% | US$3.1b | US$59.30 | PS30.8x | E62.6% | n/a |